DK0914148T3 - Behandling af partielt væksthormonoverfølsomhedssyndrom - Google Patents

Behandling af partielt væksthormonoverfølsomhedssyndrom

Info

Publication number
DK0914148T3
DK0914148T3 DK97921307T DK97921307T DK0914148T3 DK 0914148 T3 DK0914148 T3 DK 0914148T3 DK 97921307 T DK97921307 T DK 97921307T DK 97921307 T DK97921307 T DK 97921307T DK 0914148 T3 DK0914148 T3 DK 0914148T3
Authority
DK
Denmark
Prior art keywords
growth hormone
patient
igf
serum level
below normal
Prior art date
Application number
DK97921307T
Other languages
Danish (da)
English (en)
Inventor
Kenneth M Attie
Lena M S Carlsson
Neil Gesundheit
Audrey Goddard
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0914148T3 publication Critical patent/DK0914148T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK97921307T 1996-05-03 1997-04-18 Behandling af partielt væksthormonoverfølsomhedssyndrom DK0914148T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,212 US6207640B1 (en) 1994-04-07 1996-05-03 Treatment of partial growth hormone insensitivity syndrome
PCT/US1997/006652 WO1997041887A1 (en) 1996-05-03 1997-04-18 Treatment of partial growth hormone insensitivity syndrome

Publications (1)

Publication Number Publication Date
DK0914148T3 true DK0914148T3 (da) 2003-11-24

Family

ID=24579841

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97921307T DK0914148T3 (da) 1996-05-03 1997-04-18 Behandling af partielt væksthormonoverfølsomhedssyndrom

Country Status (10)

Country Link
US (1) US6207640B1 (de)
EP (2) EP0914148B1 (de)
JP (1) JP2001510444A (de)
AT (1) ATE246511T1 (de)
CA (1) CA2252560C (de)
DE (1) DE69723982T2 (de)
DK (1) DK0914148T3 (de)
ES (1) ES2205211T3 (de)
PT (1) PT914148E (de)
WO (1) WO1997041887A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
BR122013003013B8 (pt) * 1999-01-14 2021-07-06 Bolder Biotechnology Inc proteína isolada monopeguilada do hormônio do crescimento e método para sua obtenção
AU2003285286A1 (en) * 2002-09-27 2004-04-19 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor binding protein-4 and poly (ethylene glycol)
DK2274978T3 (en) * 2003-09-12 2015-06-15 Ipsen Biopharmaceuticals Inc Methods of treating an insulin-like growth factor-I (IGF-I) deficiency
KR101614983B1 (ko) * 2009-11-17 2016-04-22 입센 파마 에스.에이.에스 Ｈｇｈ 및 ｒｈｉｇｆ―１의 조합물을 위한 제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US5646113A (en) 1994-04-07 1997-07-08 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome
US5824642A (en) * 1994-04-07 1998-10-20 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome

Also Published As

Publication number Publication date
CA2252560C (en) 2010-12-14
EP1369125A1 (de) 2003-12-10
CA2252560A1 (en) 1997-11-13
JP2001510444A (ja) 2001-07-31
ES2205211T3 (es) 2004-05-01
ATE246511T1 (de) 2003-08-15
EP0914148B1 (de) 2003-08-06
DE69723982T2 (de) 2004-07-22
DE69723982D1 (de) 2003-09-11
EP0914148A1 (de) 1999-05-12
US6207640B1 (en) 2001-03-27
PT914148E (pt) 2003-12-31
WO1997041887A1 (en) 1997-11-13

Similar Documents

Publication Publication Date Title
DK0754048T3 (da) Behandling af partielt væksthormon-insentivitetssyndrom
EP0476044A4 (en) Treating disorders by application of insulin-like growth factors and analogs
DE3876052D1 (de) Medizinische verwendung.
CA2334761A1 (en) Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use
ES2101833T3 (es) Utilizacion de igf-i humano.
DE3851776D1 (de) Verwendung von IGF-II zur Behandlung von Knochenkrankheiten.
DK0914148T3 (da) Behandling af partielt væksthormonoverfølsomhedssyndrom
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
HU9202092D0 (en) An implantate composition containing biologically active protein, peptide or polypeptide
EP0515434A4 (en) Method for treating intestinal diseases
ATE183651T1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
DE69433221D1 (de) Neues Chondrozytprotein
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio